Tenax Therapeutics, Inc.
TENX
$9.01
-$0.06-0.66%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -43.33M | -31.48M | -24.21M | -17.60M | -14.56M |
| Total Depreciation and Amortization | -- | -- | -- | -- | 5.10K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 15.34M | 9.74M | 5.16M | 1.15M | 218.90K |
| Change in Net Operating Assets | 2.07M | 1.90M | 2.44M | 1.64M | 1.88M |
| Cash from Operations | -25.91M | -19.84M | -16.61M | -14.81M | -12.46M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | 200.00 |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | 200.00 |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -100.00 | -279.10K | -413.10K | -501.10K | -675.20K |
| Issuance of Common Stock | 3.69M | 2.45M | 2.17M | 1.83M | 1.83M |
| Repurchase of Common Stock | -100.24M | -100.24M | -100.24M | -100.24M | -14.19M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 123.52M | 213.99M | 213.99M | 198.78M | 112.67M |
| Cash from Financing | 26.97M | 115.92M | 115.51M | 99.87M | 99.63M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1.06M | 96.08M | 98.90M | 85.06M | 87.17M |